Joslyn Quick, a first-year MSc student in Biochemistry and Molecular Biology, was awarded the $50,000 Ronnie Miller Scholarship in Personalized Medicine.
Joslyn Quick (centre) receiving the Ronnie Miller Scholarship in Personalized Medicine at the opening of the Personalized Medicine and Individualized Drug Delivery conference at UBC.
The Ronnie Miller Scholarship in Personalized Medicine was created in honour of Ronnie Miller, past Chair of the Rx&D Board (2011) and President & CEO, Hoffmann-La Roche Limited. It was awarded to a graduate student in the UBC Department of Biochemistry & Molecular Biology, whose work will provide a significant contribution to the British Columbia Personalized Medicine Initiative.
The scholarship was presented to Quick on June 11 at the opening of the Personalized Medicine and Individualized Drug Delivery conference at UBC.
Quick is focusing her work on the treatment of advanced prostate cancer in the hopes that treatments eventually be tailored to a patient’s own genetic profile. Her supervisor is Pieter Cullis, a Professor in the Department of Biochemistry & Molecular Biology.
“My colleagues and I in the Department of Biochemistry and Molecular Biology and the Faculty of Medicine at UBC are extremely grateful to Rx&D and Hoffmann-La Roche for their wonderful act of generosity and foresight in making this donation,” said Roger Brownsey, Head of the Department of Biochemistry & Molecular Biology. “The support of young trainees is critical and yet remains a continuing challenge. Providing such support for one of our brightest young scientists will pay huge dividends in the future and is one of the best investments we can make.”